Role of sirtuins in linking metabolic syndrome with depression

Frontiers in Cellular Neuroscience

Volumn 10, Issue MAR2016, 2016, Pages

  Song, Juhyun ^a   Kim, Jongpil ^a  

^a Dongguk University   (South Korea)

Author keywords

Depression; Inflammation; Metabolic syndrome; Neurotransmitter; Sirtuins (SIRTs); Synaptic dysfunction

Indexed keywords

ACETYLCHOLINE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; DOPAMINE; INTERLEUKIN 6; NEUROTRANSMITTER; SIRTUIN; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3;

DEPRESSION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; INFLAMMATION; METABOLIC SYNDROME X; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84963739883     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2016.00086     Document Type: Review

References (142)

1. Abe, N., Uchida, S., Otsuki, K., Hobara, T., Yamagata, H., Higuchi, F., et al. (2011). Altered sirtuin deacetylase gene expression in patients with a mood disorder. J. Psychiatr. Res. 45, 1106-1112. doi: 10.1016/j.jpsychires.2011.01.016
2. Ali, S., Stone, M. A., Peters, J. L., Davies, M. J., and Khunti, K. (2006). The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet. Med. 23, 1165-1173. doi: 10.1111/j.1464-5491.2006.01943.x
3. Alvarez, V. A., and Sabatini, B. L. (2007). Anatomical and physiological plasticity of dendritic spines. Annu. Rev. Neurosci. 30, 79-97. doi: 10.1146/annurev.neuro.30.051606.094222
4. Anekonda, T. S., and Adamus, G. (2008). Resveratrol prevents antibody-induced apoptotic death of retinal cells through upregulation of Sirt1 and Ku70. BMC Res. Notes 1:122. doi: 10.1186/1756-0500-1-122
5. Antenor-Dorsey, J. A., Meyer, E., Rutlin, J., Perantie, D. C., White, N. H., Arbelaez, A. M., et al. (2013). White matter microstructural integrity in youth with type 1 diabetes.Diabetes 62, 581-589. doi: 10.2337/db12-0696
6. Antkiewicz-Michaluk, L., Wasik, A., Mozdzen, E., Romanska, I., and Michaluk, J. (2014). Antidepressant-like effect of tetrahydroisoquinoline amines in the animal model of depressive disorder induced by repeated administration of a low dose of reserpine: behavioral and neurochemical studies in the rat. Neurotox. Res. 26, 85-98. doi: 10.1007/s12640-013-9454-8
7. Banasr, M., and Duman, R. S. (2007). Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment. CNS Neurol. Disord. Drug Targets 6, 311-320. doi: 10.2174/187152707783220929
8. Barnard, K. D., Skinner, T. C., and Peveler, R. (2006). The prevalence of co-morbid depression in adults with Type 1 diabetes: systematic literature review. Diabet. Med.23, 445-448. doi: 10.1111/j.1464-5491.2006.01814.x
9. Barzilai, N., Huffman, D. M., Muzumdar, R. H., and Bartke, A. (2012). The critical role of metabolic pathways in aging. Diabetes 61, 1315-1322. doi: 10.2337/db11-1300
10. Benkert, O., Renz, A., Marano, C., and Matussek, N. (1971). Altered tyrosine daytime plasma levels in endogenous depressive patients. Arch. Gen. Psychiatry 25, 359-363. doi: 10.1001/archpsyc.1971.01750160071013
11. Bhagwagar, Z., Rabiner, E. A., Sargent, P. A., Grasby, P. M., and Cowen, P. J. (2004). Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol. Psychiatry 9, 386-392. doi: 10.1038/sj.mp.4001401
12. Blaine, B. (2008). Does depression cause obesity? A meta-analysis of longitudinal studies of depression and weight control. J. Health Psychol. 13, 1190-1197. doi: 10.1177/1359105308095977
13. Blume, J., Douglas, S. D., and Evans, D. L. (2011). Immune suppression and immune activation in depression. Brain Behav. Immun. 25, 221-229. doi: 10.1016/j.bbi.2010.10.008
14. Bordone, L., Cohen, D., Robinson, A., Motta, M. C., van Veen, E., Czopik, A., et al. (2007). SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 6, 759-767. doi: 10.1111/j.1474-9726.2007.00335.x
15. Braidy, N., Jayasena, T., Poljak, A., and Sachdev, P. S. (2012). Sirtuins in cognitive ageing and Alzheimer's disease. Curr. Opin. Psychiatry 25, 226-230. doi: 10.1097/yco.0b013e32835112c1
16. Caron, A. Z., He, X., Mottawea, W., Seifert, E. L., Jardine, K., Dewar-Darch, D., et al. (2014). The SIRT1 deacetylase protects mice against the symptoms of metabolic syndrome. FASEB J. 28, 1306-1316. doi: 10.1096/fj.13-243568
17. Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., et al. (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386-389. doi: 10.1126/science.1083968
18. Chen, C. J., Fu, Y. C., Yu, W., and Wang, W. (2013). SIRT3 protects cardiomyocytes from oxidative stress-mediated cell death by activating NF-κB. Biochem. Biophys. Res. Commun. 430, 798-803. doi: 10.1016/j.bbrc.2012.11.066
19. Chen, H., Wu, D., Ding, X., and Ying, W. (2015). SIRT2 is required for lipopolysaccharide-induced activation of BV2 microglia. Neuroreport 26, 88-93. doi: 10.1097/wnr.0000000000000305
20. Cheng, H. L., Mostoslavsky, R., Saito, S., Manis, J. P., Gu, Y., Patel, P., et al. (2003). Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc. Natl. Acad. Sci. U S A 100, 10794-10799. doi: 10.1073/pnas.1934713100
21. Chowdhury, S. K., Dobrowsky, R. T., and Fernyhough, P. (2011). Nutrient excess and altered mitochondrial proteome and function contribute to neurodegeneration in diabetes. Mitochondrion 11, 845-854. doi: 10.1016/j.mito.2011.06.007
22. Codocedo, J. F., Allard, C., Godoy, J. A., Varela-Nallar, L., and Inestrosa, N. C. (2012). SIRT1 regulates dendritic development in hippocampal neurons. PLoS One 7:e47073. doi: 10.1371/journal.pone.0047073
23. Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., et al. (2004). Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305, 390-392. doi: 10.1126/science.1099196
24. Colman, R. J., Anderson, R. M., Johnson, S. C., Kastman, E. K., Kosmatka, K. J., Beasley, T. M., et al. (2009). Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 325, 201-204. doi: 10.1126/science.1173635
25. Conradi, H. J., Ormel, J., and de Jonge, P. (2011). Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study. Psychol. Med. 41, 1165-1174. doi: 10.1017/s0033291710001911
26. Coppen, A. (1967). The biochemistry of affective disorders. Br. J. Psychiatry 113, 1237-1264.
27. Coupland, N. J., Ogilvie, C. J., Hegadoren, K. M., Seres, P., Hanstock, C. C., and Allen, P. S. (2005). Decreased prefrontal Myo-inositol in major depressive disorder. Biol. Psychiatry 57, 1526-1534. doi: 10.1016/j.biopsych.2005.02.027
28. Dai, S. H., Chen, T., Wang, Y. H., Zhu, J., Luo, P., Rao, W., et al. (2014). Sirt3 protects cortical neurons against oxidative stress via regulating mitochondrial Ca2+ and mitochondrial biogenesis. Int. J. Mol. Sci. 15, 14591-14609. doi: 10.3390/ijms150814591
29. Dailly, E., Chenu, F., Renard, C. E., and Bourin, M. (2004). Dopamine, depression and antidepressants. Fundam. Clin. Pharmacol. 18, 601-607. doi: 10.1111/j.1472-8206.2004.00287.x
30. Daitoku, H., Hatta, M., Matsuzaki, H., Aratani, S., Ohshima, T., Miyagishi, M., et al. (2004). Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc. Natl. Acad. Sci. U S A. 101, 10042-10047. doi: 10.1073/pnas.0400593101
31. Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., and Kelley, K. W. (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9, 46-56. doi: 10.1038/nrn2297
32. de Souza, C. M., and Hidalgo, M. P. (2012). World Health Organization 5-item well-being index: validation of the Brazilian Portuguese version. Eur. Arch. Psychiatry Clin. Neurosci. 262, 239-244. doi: 10.1007/s00406-011-0255-x
33. Delgado, P. L. (2000). Depression: the case for a monoamine deficiency. J. Clin. Psychiatry 61 Suppl 6, 7-11.
34. Deng, S., Zhu, S., Wang, B., Li, X., Liu, Y., Qin, Q., et al. (2014). Chronic pancreatitis and pancreatic cancer demonstrate active epithelial-mesenchymal transition profile, regulated by miR-217-SIRT1 pathway. Cancer Lett. 355, 184-191. doi: 10.1016/j.canlet.2014.08.007
35. Donmez, G., and Outeiro, T. F. (2013). SIRT1 and SIRT2: emerging targets in neurodegeneration. EMBO Mol. Med. 5, 344-352. doi: 10.1002/emmm.201302451
36. Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., et al. (2010). A meta-analysis of cytokines in major depression. Biol. Psychiatry 67, 446-457. doi: 10.1016/j.biopsych.2009.09.033
37. Drevets, W. C., Thase, M. E., Moses-Kolko, E. L., Price, J., Frank, E., Kupfer, D. J., et al. (2007). Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl. Med. Biol. 34, 865-877. doi: 10.1016/j.nucmedbio.2007.06.008
38. Duan, W., and Mattson, M. P. (1999). Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J. Neurosci. Res. 57, 195-206. doi: 10.1002/(sici)1097-4547(19990715)57:2<195::aid-jnr5>3.0.co;2-p
39. Duric, V., Banasr, M., Stockmeier, C. A., Simen, A. A., Newton, S. S., Overholser, J. C., et al. (2013). Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects. Int. J. Neuropsychopharmacol. 16, 69-82. doi: 10.1017/s1461145712000016
40. Etkin, A., Gyurak, A., and O'Hara, R. (2013). A neurobiological approach to the cognitive deficits of psychiatric disorders. Dialogues Clin. Neurosci. 15, 419-429.
41. Fakhoury, M. (2015). Revisiting the serotonin hypothesis: implications for major depressive disorders. Mol. Neurobiol. doi: 10.1007/s12035-015-9152-z [Epub ahead of print].
42. Ferland, C. L., Hawley, W. R., Puckett, R. E., Wineberg, K., Lubin, F. D., Dohanich, G. P., et al. (2013). Sirtuin activity in dentate gyrus contributes to chronic stress-induced behavior and extracellular signal-regulated protein kinases 1 and 2 cascade changes in the hippocampus. Biol. Psychiatry 74, 927-935. doi: 10.1016/j.biopsych.2013.07.029
43. Gao, L., Chao, L., and Chao, J. (2010). A novel signaling pathway of tissue kallikrein in promoting keratinocyte migration: activation of proteinase-activated receptor 1 and epidermal growth factor receptor. Exp. Cell Res. 316, 376-389. doi: 10.1016/j.yexcr.2009.10.022
44. Gareri, P., Castagna, A., Cotroneo, A. M., Putignano, S., De Sarro, G., and Bruni, A. C. (2015). The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages and doubts for an old drug with new perspectives.Clin. Interv. Aging 10, 1421-1429. doi: 10.2147/cia.s87886
45. Geissler, A., Frund, R., Scholmerich, J., Feuerbach, S., and Zietz, B. (2003). Alterations of cerebral metabolism in patients with diabetes mellitus studied by proton magnetic resonance spectroscopy. Exp. Clin. Endocrinol. Diabetes. 111, 421-427. doi: 10.1055/s-2003-44289
46. Guarente, L. (2006). Sirtuins as potential targets for metabolic syndrome. Nature444, 868-874. doi: 10.1038/nature05486
47. Guo, W., Qian, L., Zhang, J., Zhang, W., Morrison, A., Hayes, P., et al. (2011). Sirt1 overexpression in neurons promotes neurite outgrowth and cell survival through inhibition of the mTOR signaling. J. Neurosci. Res. 89, 1723-1736. doi: 10.1002/jnr.22725
48. Hamer, M., Batty, G. D., and Kivimaki, M. (2012). Risk of future depression in people who are obese but metabolically healthy: the English longitudinal study of ageing. Mol. Psychiatry 17, 940-945. doi: 10.1038/mp.2012.30
49. Hammer, S., Snel, M., Lamb, H. J., Jazet, I. M., van der Meer, R. W., Pijl, H., et al. (2008). Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J. Am. Coll. Cardiol. 52, 1006-1012. doi: 10.1016/j.jacc.2008.04.068
50. Han, S. H. (2009). Potential role of sirtuin as a therapeutic target for neurodegenerative diseases. J. Clin. Neurol. 5, 120-125. doi: 10.3988/jcn.2009.5.3.120
51. Hannestad, J., DellaGioia, N., and Bloch, M. (2011). The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.Neuropsychopharmacology 36, 2452-2459. doi: 10.1038/npp.2011.132
52. Harry, G. J., and Kraft, A. D. (2012). Microglia in the developing brain: a potential target with lifetime effects. Neurotoxicology 33, 191-206. doi: 10.1016/j.neuro.2012.01.012
53. Hashioka, S., Klegeris, A., Monji, A., Kato, T., Sawada, M., McGeer, P. L., et al. (2007). Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide. Exp. Neurol. 206, 33-42. doi: 10.1016/j.expneurol.2007.03.022
54. Hernandez-Jimenez, M., Hurtado, O., Cuartero, M. I., Ballesteros, I., Moraga, A., Pradillo, J. M., et al. (2013). Silent information regulator 1 protects the brain against cerebral ischemic damage. Stroke 44, 2333-2337. doi: 10.1161/strokeaha.113.001715
55. Hsu, C. P., Zhai, P., Yamamoto, T., Maejima, Y., Matsushima, S., Hariharan, N., et al. (2010). Silent information regulator 1 protects the heart from ischemia/reperfusion.Circulation 122, 2170-2182. doi: 10.1161/circulationaha.110.958033
56. Hu, W., Guan, L. S., Dang, X. B., Ren, P. Y., and Zhang, Y. L. (2014). Small-molecule inhibitors at the PSD-95/nNOS interface attenuate MPP+-induced neuronal injury through Sirt3 mediated inhibition of mitochondrial dysfunction. Neurochem. Int. 79, 57-64. doi: 10.1016/j.neuint.2014.10.005
57. Huang, P. S., Son, J. H., Abbott, L. C., and Winzer-Serhan, U. H. (2011). Regulated expression of neuronal SIRT1 and related genes by aging and neuronal β2-containing nicotinic cholinergic receptors. Neuroscience 196, 189-202. doi: 10.1016/j.neuroscience.2011.09.007
58. Jaeger, J., Berns, S., Uzelac, S., and Davis-Conway, S. (2006). Neurocognitive deficits and disability in major depressive disorder. Psychiatry Res. 145, 39-48. doi: 10.1016/j.psychres.2005.11.011
59. Jeong, J., Juhn, K., Lee, H., Kim, S. H., Min, B. H., Lee, K. M., et al. (2007). SIRT1 promotes DNA repair activity and deacetylation of Ku70. Exp. Mol. Med. 39, 8-13. doi: 10.1038/emm.2007.2
60. Karg, K., Burmeister, M., Shedden, K., and Sen, S. (2011). The serotonin transporter promoter variant (5-HTTLPR), stress and depression meta-analysis revisited: evidence of genetic moderation. Arch. Gen. Psychiatry 68, 444-454. doi: 10.1001/archgenpsychiatry.2010.189
61. Kauer, J. A., and Malenka, R. C. (2007). Synaptic plasticity and addiction. Nat. Rev. Neurosci. 8, 844-858. doi: 10.1038/nrn2234
62. Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., et al. (2003). The epidemiology of major depressive disorder: results from the national comorbidity survey replication (NCS-R). JAMA 289, 3095-3105. doi: 10.1001/jama.289.23.3095
63. Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R., and Walters, E. E. (2005). Prevalence, severity and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch. Gen. Psychiatry 62, 617-627. doi: 10.1001/archpsyc.62.6.617
64. Kessler, R. C., Ormel, J., Petukhova, M., McLaughlin, K. A., Green, J. G., Russo, L. J., et al. (2011). Development of lifetime comorbidity in the World Health Organization world mental health surveys. Arch. Gen. Psychiatry 68, 90-100. doi: 10.1001/archgenpsychiatry.2010.180
65. Kim, D., Nguyen, M. D., Dobbin, M. M., Fischer, A., Sananbenesi, F., Rodgers, J. T., et al. (2007). SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J. 26, 3169-3179. doi: 10.1038/sj.emboj.7601758
66. Kim, H. S., Patel, K., Muldoon-Jacobs, K., Bisht, K. S., Aykin-Burns, N., Pennington, J. D., et al. (2010). SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 17, 41-52. doi: 10.1016/j.ccr.2009.11.023
67. Krogh, J., Benros, M. E., Jorgensen, M. B., Vesterager, L., Elfving, B., and Nordentoft, M. (2014). The association between depressive symptoms, cognitive function and inflammation in major depression. Brain Behav. Immun. 35, 70-76. doi: 10.1016/j.bbi.2013.08.014
68. Lanfumey, L., and Hamon, M. (2004). 5-HT1 receptors. Curr. Drug Targets CNS Neurol. Disord. 3, 1-10. doi: 10.2174/1568007043482570
69. Lanfumey, L., Mongeau, R., Cohen-Salmon, C., and Hamon, M. (2008). Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders. Neurosci. Biobehav. Rev. 32, 1174-1184. doi: 10.1016/j.neubiorev.2008.04.006
70. Levitan, R. D., Davis, C., Kaplan, A. S., Arenovich, T., Phillips, D. I., and Ravindran, A. V. (2012). Obesity comorbidity in unipolar major depressive disorder: refining the core phenotype. J. Clin. Psychiatry 73, 1119-1124. doi: 10.4088/jcp.11m07394
71. Libert, S., Pointer, K., Bell, E. L., Das, A., Cohen, D. E., Asara, J. M., et al. (2011). SIRT1 activates MAO-A in the brain to mediate anxiety and exploratory drive. Cell147, 1459-1472. doi: 10.1016/j.cell.2011.10.054
72. Liu, R., Dang, W., Du, Y., Zhou, Q., Jiao, K., and Liu, Z. (2015). SIRT2 is involved in the modulation of depressive behaviors. Sci. Rep. 5: 8415. doi: 10.1038/srep08415
73. Liu, Y., Ho, R. C., and Mak, A. (2012). Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J. Affect Disord. 139, 230-239. doi: 10.1016/j.jad.2011.08.003
74. Lohoff, F. W. (2010). Overview of the genetics of major depressive disorder. Curr. Psychiatry Rep. 12, 539-546. doi: 10.1007/s11920-010-0150-6
75. Lopez, A. D., and Mathers, C. D. (2006). Measuring the global burden of disease and epidemiological transitions. 2002-2030. Ann. Trop. Med. Parasitol. 100, 481-499. doi: 10.1179/136485906x97417
76. Luppino, F. S., de Wit, L. M., Bouvy, P. F., Stijnen, T., Cuijpers, P., Penninx, B. W., et al. (2010). Overweight, obesity and depression: a systematic review and meta-analysis of longitudinal studies. Arch. Gen. Psychiatry 67, 220-229. doi: 10.1001/archgenpsychiatry.2010.2
77. Maciag, D., Hughes, J., O'Dwyer, G., Pride, Y., Stockmeier, C. A., Sanacora, G., et al. (2010). Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies. Biol. Psychiatry 67, 465-470. doi: 10.1016/j.biopsych.2009.10.027
78. Maes, M., Bosmans, E., Suy, E., Vandervorst, C., DeJonckheere, C., and Raus, J. (1991). Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin 1β and soluble interleukin-2 receptor production. Acta Psychiatr. Scand. 84, 379-386. doi: 10.1111/j.1600-0447.1991.tb03163.x
79. Maes, M., Leonard, B. E., Myint, A. M., Kubera, M., and Verkerk, R. (2011). The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry. 35, 702-721. doi: 10.1016/j.pnpbp.2010.12.017
80. Mallick, S., and D'Mello, S. R. (2014). JAZ (Znf346), a SIRT1-interacting protein, protects neurons by stimulating p21 (WAF/CIP1) protein expression. J. Biol. Chem.289, 35409-35420. doi: 10.1074/jbc.m114.597575
81. Marchal, J., Blanc, S., Epelbaum, J., Aujard, F., and Pifferi, F. (2012). Effects of chronic calorie restriction or dietary resveratrol supplementation on insulin sensitivity markers in a primate, Microcebus murinus. PloS One 7:e34289. doi: 10.1371/journal.pone.0034289
82. Martinowich, K., Manji, H., and Lu, B. (2007). New insights into BDNF function in depression and anxiety. Nat. Neurosci. 10, 1089-1093. doi: 10.1038/nn1971
83. McGaugh, J. L. (2000). Memory-a century of consolidation. Science 287, 248-251. doi: 10.1126/science.287.5451.248
84. McIntyre, R. S., Soczynska, J. K., Konarski, J. Z., Woldeyohannes, H. O., Law, C. W., Miranda, A., et al. (2007). Should depressive syndromes be reclassified as "metabolic syndrome type II"? Ann. Clin. Psychiatry 19, 257-264. doi: 10.1080/10401230701653377
85. Meerson, A., Cacheaux, L., Goosens, K. A., Sapolsky, R. M., Soreq, H., and Kaufer, D. (2010). Changes in brain MicroRNAs contribute to cholinergic stress reactions. J. Mol. Neurosci. 40, 47-55. doi: 10.1007/s12031-009-9252-1
86. Michan, S., and Sinclair, D. (2007). Sirtuins in mammals: insights into their biological function. Biochem. J. 404, 1-13. doi: 10.1042/bj20070140
87. Michan, S., Li, Y., Chou, M. M., Parrella, E., Ge, H., Long, J. M., et al. (2010). SIRT1 is essential for normal cognitive function and synaptic plasticity. J. Neurosci. 30, 9695-9707. doi: 10.1523/jneurosci.0027-10.2010
88. Miller, A. H., Maletic, V., and Raison, C. L. (2009). Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 65, 732-741. doi: 10.1016/j.biopsych.2008.11.029
89. Miller, A. H., Pariante, C. M., and Pearce, B. D. (1999). Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression. Adv. Exp. Med. Biol. 461, 107-116. doi: 10.1007/978-0-585-37970-8_7
90. Morales-Medina, J. C., Juarez, I., Venancio-Garcia, E., Cabrera, S. N., Menard, C., Yu, W., et al. (2013). Impaired structural hippocampal plasticity is associated with emotional and memory deficits in the olfactory bulbectomized rat. Neuroscience 236, 233-243. doi: 10.1016/j.neuroscience.2013.01.037
91. Morris, K. C., Lin, H. W., Thompson, J. W., and Perez-Pinzon, M. A. (2011). Pathways for ischemic cytoprotection: role of sirtuins in caloric restriction, resveratrol and ischemic preconditioning. J. Cereb. Blood. Flow. Metab. 31, 1003-1019. doi: 10.1038/jcbfm.2010.229
92. Mortuza, R., Chen, S., Feng, B., Sen, S., and Chakrabarti, S. (2013). High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway. PLoS One 8:e54514. doi: 10.1371/journal.pone.0054514
93. Murrough, J. W., Iacoviello, B., Neumeister, A., Charney, D. S., and Iosifescu, D. V. (2011). Cognitive dysfunction in depression: neurocircuitry and new therapeutic strategies. Neurobiol. Learn. Mem. 96, 553-563. doi: 10.1016/j.nlm.2011.06.006
94. Musen, G., Jacobson, A. M., Bolo, N. R., Simonson, D. C., Shenton, M. E., McCartney, R. L., et al. (2012). Resting-state brain functional connectivity is altered in type 2 diabetes. Diabetes 61, 2375-2379. doi: 10.2337/db11-1669
95. Nakagawa, T., and Guarente, L. (2011). Sirtuins at a glance. J. Cell Sci. 124, 833-838. doi: 10.1242/jcs.081067
96. Negishi, M., and Katoh, H. (2002). Rho family GTPases as key regulators for neuronal network formation. J. Biochem. 132, 157-166. doi: 10.1093/oxfordjournals.jbchem.a003205
97. Nerurkar, P. V., and Nerurkar, V. R. (2008). Respected Sir(2): magic target for diabetes. Cellscience 4, 82-96.
98. Nie, H., Li, Y., Wang, C., Chen, X., Liu, B., Wu, D., et al. (2014). SIRT2 plays a key role in both cell cycle regulation and cell survival of BV2 microglia. Int. J. Physiol. Pathophysiol. Pharmacol. 6, 166-171.
99. Nordquist, N., and Oreland, L. (2010). Serotonin, genetic variability, behaviour and psychiatric disorders-a review. Ups. J. Med. Sci. 115, 2-10. doi: 10.3109/03009730903573246
100. Nutt, D. J. (2008). Relationship of neurotransmitters to the symptoms of major depressive disorder. J. Clin. Psychiatry 69 Suppl E1, 4-7. doi: 10.1007/springerreference_116852
101. Pais, T. F., Szego, E. M., Marques, O., Miller-Fleming, L., Antas, P., Guerreiro, P., et al. (2013). The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation. EMBO J. 32, 2603-2616. doi: 10.1038/emboj.2013.200
102. Pan, A., Keum, N., Okereke, O. I., Sun, Q., Kivimaki, M., Rubin, R. R., et al. (2012). Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care 35, 1171-1180. doi: 10.2337/dc11-2055
103. Paraiso, A. F., Mendes, K. L., and Santos, S. H. (2013). Brain activation of SIRT1: role in neuropathology. Mol. Neurobiol. 48, 681-689. doi: 10.1007/s12035-013-8459-x
104. Patel, N. V., Gordon, M. N., Connor, K. E., Good, R. A., Engelman, R. W., Mason, J., et al. (2005). Caloric restriction attenuates Aβ-deposition in Alzheimer transgenic models. Neurobiol. Aging 26, 995-1000. doi: 10.1016/j.neurobiolaging.2004.09.014
105. Pellegrini, L., Pucci, B., Villanova, L., Marino, M. L., Marfe, G., Sansone, L., et al. (2012). SIRT3 protects from hypoxia and staurosporine-mediated cell death by maintaining mitochondrial membrane potential and intracellular pH. Cell Death Differ. 19, 1815-1825. doi: 10.1038/cdd.2012.62
106. Picciotto, M. R., Lewis, A. S., van Schalkwyk, G. I., and Mineur, Y. S. (2015). Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states. Neuropharmacology 96, 235-243. doi: 10.1016/j.neuropharm.2014.12.028
107. Pittenger, C., and Duman, R. S. (2008). Stress, depression and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 33, 88-109. doi: 10.1038/sj.npp.1301574
108. Prud'Homme, G. J., Glinka, Y., Udovyk, O., Hasilo, C., Paraskevas, S., and Wang, Q. (2014). GABA protects pancreatic beta cells against apoptosis by increasing SIRT1 expression and activity. Biochem. Biophys. Res. Commun. 452, 649-654. doi: 10.1016/j.bbrc.2014.08.135
109. Raison, C. L., Capuron, L., and Miller, A. H. (2006). Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 27, 24-31. doi: 10.1016/j.it.2005.11.006
110. Rajkowska, G., O'Dwyer, G., Teleki, Z., Stockmeier, C. A., and Miguel-Hidalgo, J. J. (2007). GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology 32, 471-482. doi: 10.1038/sj.npp.1301234
111. Rao, Y. S., Mott, N. N., Wang, Y., Chung, W. C., and Pak, T. R. (2013). MicroRNAs in the aging female brain: a putative mechanism for age-specific estrogen effects.Endocrinology 154, 2795-2806. doi: 10.1210/en.2013-1230
112. Reijmer, Y. D., Brundel, M., de Bresser, J., Kappelle, L. J., Leemans, A., Biessels, G. J., et al. (2013). Microstructural white matter abnormalities and cognitive functioning in type 2 diabetes: a diffusion tensor imaging study. Diabetes Care 36, 137-144. doi: 10.2337/dc12-0493
113. Revollo, J. R., Korner, A., Mills, K. F., Satoh, A., Wang, T., Garten, A., et al. (2007). Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab. 6, 363-375. doi: 10.1016/j.cmet.2007.09.003
114. Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., and Puigserver, P. (2005). Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1. Nature 434, 113-118. doi: 10.1038/nature03354
115. Rodriguez-Ortiz, C. J., Baglietto-Vargas, D., Martinez-Coria, H., LaFerla, F. M., and Kitazawa, M. (2014). Upregulation of miR-181 decreases c-Fos and SIRT-1 in the hippocampus of 3xTg-AD mice. J. Alzheimers Dis. 42, 1229-1238. doi: 10.3233/JAD-140204
116. Roiser, J. P., Elliott, R., and Sahakian, B. J. (2012). Cognitive mechanisms of treatment in depression. Neuropsychopharmacology 37, 117-136. doi: 10.1038/npp.2011.183
117. Rotella, F., and Mannucci, E. (2013). Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. J. Clin. Psychiatry 74, 31-37. doi: 10.1016/j.diabres.2012.11.022
118. Ruhe, H. G., Mason, N. S., and Schene, A. H. (2007). Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol. Psychiatry 12, 331-359. doi: 10.1038/sj.mp.4001949
119. Russo, S. J., and Nestler, E. J. (2013). The brain reward circuitry in mood disorders.Nat. Rev. Neurosci. 14, 609-625. doi: 10.1038/nrn3381
120. Sahin, I., Alkan, A., Keskin, L., Cikim, A., Karakas, H. M., Firat, A. K., et al. (2008). Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.J. Diabetes Complicat. 22, 254-260. doi: 10.1016/j.jdiacomp.2007.03.007
121. Schenk, S., McCurdy, C. E., Philp, A., Chen, M. Z., Holliday, M. J., Bandyopadhyay, G. K., et al. (2011). Sirt1 enhances skeletal muscle insulin sensitivity in mice during caloric restriction. J. Clin. Invest. 121, 4281-4288. doi: 10.1172/JCI58554
122. Schwer, B., North, B. J., Frye, R. A., Ott, M., and Verdin, E. (2002). The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J. Cell Biol. 158, 647-657. doi: 10.1083/jcb.200205057
123. Sekita, A., Arima, H., Ninomiya, T., Ohara, T., Doi, Y., Hirakawa, Y., et al. (2013). Elevated depressive symptoms in metabolic syndrome in a general population of Japanese men: a cross-sectional study. BMC Public Health 13: 862. doi: 10.1186/1471-2458-13-862
124. Shih, J., Liu, L., Mason, A., Higashimori, H., and Donmez, G. (2014). Loss of SIRT4 decreases GLT-1-dependent glutamate uptake and increases sensitivity to kainic acid.J. Neurochem. 131, 573-581. doi: 10.1111/jnc.12942
125. Shimon, H., Agam, G., Belmaker, R. H., Hyde, T. M., and Kleinman, J. E. (1997). Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder. Am. J. Psychiatry 154, 1148-1150. doi: 10.1176/ajp.154.8.1148
126. Silva, N., Atlantis, E., and Ismail, K. (2012). A review of the association between depression and insulin resistance: pitfalls of secondary analyses or a promising new approach to prevention of type 2 diabetes? Curr. Psychiatry Rep. 14, 8-14. doi: 10.1007/s11920-011-0245-8
127. Silvestre, M. F., Viollet, B., Caton, P. W., Leclerc, J., Sakakibara, I., Foretz, M., et al. (2014). The AMPK-SIRT signaling network regulates glucose tolerance under calorie restriction conditions. Life Sci. 100, 55-60. doi: 10.1016/j.lfs.2014.01.080
128. Smith, D. L., Nagy, T. R., and Allison, D. B. (2010). Calorie restriction: what recent results suggest for the future of ageing research. Eur. J. Clin. Invest. 40, 440-450. doi: 10.1111/j.1365-2362.2010.02276.x
129. Tennen, R. I., Berber, E., and Chua, K. F. (2010). Functional dissection of SIRT6: identification of domains that regulate histone deacetylase activity and chromatin localization. Mech. Ageing Dev. 131, 185-192. doi: 10.1016/j.mad.2010.01.006
130. Toups, M. S., Myers, A. K., Wisniewski, S. R., Kurian, B., Morris, D. W., Rush, A. J., et al. (2013). Relationship between obesity and depression: characteristics and treatment outcomes with antidepressant medication. Psychosom. Med. 75, 863-872. doi: 10.1097/psy.0000000000000000
131. Trivedi, M. H., and Greer, T. L. (2014). Cognitive dysfunction in unipolar depression: implications for treatment. J. Affect Disord. 152-154, 19-27. doi: 10.1016/j.jad.2013.09.012
132. van Duinkerken, E., Schoonheim, M. M., Ijzerman, R. G., Klein, M., Ryan, C. M., Moll, A. C., et al. (2012a). Diffusion tensor imaging in type 1 diabetes: decreased white matter integrity relates to cognitive functions. Diabetologia 55, 1218-1220. doi: 10.1007/s00125-012-2488-2
133. van Duinkerken, E., Schoonheim, M. M., Sanz-Arigita, E. J., IJzerman, R. G., Moll, A. C., Snoek, F. J., et al. (2012b). Resting-state brain networks in type 1 diabetic patients with and without microangiopathy and their relation to cognitive functions and disease variables. Diabetes 61, 1814-1821. doi: 10.2337/db11-1358
134. Vaziri, H., Dessain, S. K., Ng Eaton, E., Imai, S. I., Frye, R. A., Pandita, T. K., et al. (2001). hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107, 149-159. doi: 10.1016/S0092-8674(01)00527-X
135. Wang, Q., Liu, M., Liu, W. W., Hao, W. B., Tashiro, S., Onodera, S., et al. (2012). In vivo recovery effect of silibinin treatment on streptozotocin-induced diabetic mice is associated with the modulations of Sirt-1 expression and autophagy in pancreatic beta-cell. J. Asian Nat. Prod. Res. 14, 413-423. doi: 10.1080/10286020.2012.657180
136. Wang, X., Guan, Q., Wang, M., Yang, L., Bai, J., Yan, Z., et al. (2015). Aging-related rotenone-induced neurochemical and behavioral deficits: role of SIRT2 and redox imbalance and neuroprotection by AK-7. Drug Des. Devel. Ther. 9, 2553-2563. doi: 10.2147/dddt.s81539
137. Wong, M. L., Dong, C., Maestre-Mesa, J., and Licinio, J. (2008). Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Mol. Psychiatry 13, 800-812. doi: 10.1038/mp.2008.59
138. Xiao, C., Kim, H. S., Lahusen, T., Wang, R. H., Xu, X., Gavrilova, O., et al. (2010). SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated glucose uptake in mice. J. Biol. Chem. 285, 36776-36784. doi: 10.1074/jbc.m110.168039
139. Yang, H., Yang, T., Baur, J. A., Perez, E., Matsui, T., Carmona, J. J., et al. (2007). Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 130, 1095-1107.
140. Ye, J., Liu, Z., Wei, J., Lu, L., Huang, Y., Luo, L., et al. (2013). Protective effect of SIRT1 on toxicity of microglial-derived factors induced by LPS to PC12 cells via the p53-caspase-3-dependent apoptotic pathway. Neurosci. Lett. 553, 72-77. doi: 10.1016/j.neulet.2013.08.020
141. Yuen, E. Y., Liu, W., Karatsoreos, I. N., Feng, J., McEwen, B. S., and Yan, Z. (2009). Acute stress enhances glutamatergic transmission in prefrontal cortex and facilitates working memory. Proc. Natl. Acad. Sci. U S A 106, 14075-14079. doi: 10.1073/pnas.0906791106
142. Zanoveli, J. M., de Morais, H., da Silva Dias, I. C., Schreiber, A. K., de Souza, C. P., and da Cunha, J. M. (2015). Depression associated with diabetes: from pathophysiology to treatment. Curr. Diabetes Rev. doi: 10.1159/000319510